Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics and network-based screening and discovery of potential molecular targets and small molecular drugs for breast cancer. | Front Pharmacol | 2022 | 36204232 | PubTator, text mining | PubMed |
| Screening of Sepsis Biomarkers Based on Bioinformatics Data Analysis. | J Healthc Eng | 2022 | 36199375 | PubTator, text mining | PubMed |
| Extracranial arteriovenous malformations demonstrate dysregulated TGF-β/BMP signaling and increased circulating TGF-β1. | Sci Rep | 2022 | 36198763 | PubTator, text mining | PubMed |
| Bioinformatics analysis of inflammation and oncology in pulmonary lymphangioleiomyomatosis. | Medicine (Baltimore) | 2022 | 36197266 | PubTator, text mining | PubMed |
| OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications. | Front Immunol | 2022 | 36189271 | PubTator, text mining | PubMed |
| Identifying potential therapeutic targets for ischemic stroke through immune infiltration analysis and construction of a programmed cell death‑related ceRNA network. | Exp Ther Med | 2022 | 36185765 | PubTator, text mining | PubMed |
| Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta. | Arterioscler Thromb Vasc Biol | 2022 | 36172868 | PubTator, text mining | PubMed |
| Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension. | Front Genet | 2022 | 36171892 | PubTator, text mining | PubMed |
| Genome-wide expression screening in the cardiac embryonic stem cell test shows additional differentiation routes that are regulated by morpholines and piperidines. | Curr Res Toxicol | 2022 | 36157598 | PubTator, text mining | PubMed |
| Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential. | Front Chem | 2022 | 36157032 | PubTator, text mining | PubMed |
| Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer. | World J Gastroenterol | 2022 | 36156927 | PubTator, text mining | PubMed |
| Screening Potential Diagnostic Biomarkers for Age-Related Sarcopenia in the Elderly Population by WGCNA and LASSO. | Biomed Res Int | 2022 | 36147639 | PubTator, text mining | PubMed |
| Heparan Sulfate: A Regulator of White Adipocyte Differentiation and of Vascular/Adipocyte Interactions. | Biomedicines | 2022 | 36140217 | PubTator, text mining | PubMed |
| Pan-cancer gene expression analysis of tissue microarray using EdgeSeq oncology biomarker panel and a cross-comparison with HER2 and HER3 immunohistochemical analysis. | PLoS One | 2022 | 36137139 | PubTator, text mining | PubMed |
| Molecular Profile Changes in Patients with Castrate-Resistant Prostate Cancer Pre- and Post-Abiraterone/Prednisone Treatment. | Mol Cancer Res | 2022 | 36135372 | PubTator, text mining | PubMed |
| The transcriptional coactivator Eya1 exerts transcriptional repressive activity by interacting with REST corepressors and REST-binding sequences to maintain nephron progenitor identity. | Nucleic Acids Res | 2022 | 36130284 | PubTator, text mining | PubMed |
| Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. | Front Immunol | 2022 | 36119022 | PubTator, text mining | PubMed |
| A novel role of follicle-stimulating hormone (FSH) in various regeneration-related functions of endometrial stem cells. | Exp Mol Med | 2022 | 36117220 | PubTator, text mining | PubMed |
| Changes in patient peripheral blood cell microRNAs after total body irradiation during hematopoietic stem cell transplantation. | Ann Transl Med | 2022 | 36110996 | PubTator, text mining | PubMed |
| Low expression of INHB co-receptor TGFBR3 in connection with metastasis and immune infiltration in lung adenocarcinoma. | Am J Transl Res | 2022 | 36105051 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=24